Search All News
Source:American Association for Cancer Research
In a new study from Columbia Radiology, researchers utilized artificial intelligence (AI) to train algorithms to predict tumor sensitivity to three systemic cancer therapies.
A few questions when scheduling an MRI cancer will help patients determine whether the system can give them the quality needed for accurate prostate cancer diagnosis.
Richard Ha, MD of Columbia Radiology discusses his latest study involving the use of AI to predict how breast tumors will respond to chemotherapy.
- March 28, 2017
Columbia and NewYork-Presbyterian to participate in program led by the Foundation for the National Institutes of Health Biomarkers Consortium